“Benign” Metastasizing Fibrous Histiocytoma Harboring PRKCD Gene Fusions With Malignant Clinical Course
- 18 November 2025
- journal article
- case report
- Published by Wiley in Genes, Chromosomes and Cancer
- Vol. 64 (11) , e70094
Abstract
Dermatofibroma/fibrous histiocytoma is a common tumor of the dermis, composed of myofibroblasts, dendrocytes, and macrophages with characteristic entrapment of dermal collagen fibers at the periphery of the tumor. Various subtypes of dermatofibroma, including cellular, aneurysmal, and atypical dermatofibroma, are associated with an increased risk of recurrence, especially with incomplete excision. Two cases of benign fibrous histiocytoma with recurrence and metastasis are described. Patient 1 had a cellular fibrous histiocytoma with KIRREL1 :: PRKCD fusion presenting as a superficial and deep soft tissue mass involving the scapula and lateral clavicle. Patient 1 subsequently developed metastasis to the chest wall and thigh. Patient 2 had a recurrent aneurysmal fibrous histiocytoma with LAMTOR1 :: PRKCD fusion presenting as a large shoulder mass with invasion of the clavicle and lymph node metastasis. Patient 2 developed rapid local recurrence and PET‐avid pulmonary nodules, radiologically consistent with metastasis. Fibrous histiocytoma is typically a morphologically benign neoplasm that only rarely exhibits clinically aggressive behavior with multiple recurrences and metastases. Although uncommon, recognition of this entity is important so that pathologists and sarcoma oncologists can ensure accurate diagnosis, multidisciplinary management, and appropriate clinical surveillance. In addition, complex chromosomal abnormalities may serve as useful indicators of fibrous histiocytoma with the risk of aggressive clinical behavior.Keywords
This publication has 16 references indexed in Scilit:
- Metastasizing aneurysmal dermatofibroma initially diagnosed as angiosarcoma confirmed by CD63::PRKCD fusion gene detection with nanopore sequencingGenes, Chromosomes and Cancer, 2024
- Transmembrane protein KIRREL1 regulates Hippo signaling via a feedback loop and represents a therapeutic target in YAP/TAZ-active cancersCell Reports, 2022
- Mutations in KIRREL1, a slit diaphragm component, cause steroid-resistant nephrotic syndromeKidney International, 2019
- LAMTOR/Ragulator is a negative regulator of Arl8b- and BORC-dependent late endosomal positioningJournal of Cell Biology, 2017
- PPP6R3‐USP6 amplification: Novel oncogenic mechanism in malignant nodular fasciitisGenes, Chromosomes and Cancer, 2016
- LAMTOR1-PRKCD and NUMA1-SFMBT1 fusion genes identified by RNA sequencing in aneurysmal benign fibrous histiocytoma with t(3;11)(p21;q13)Cancer Genetics, 2015
- Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencingLaboratory Investigation, 2015
- SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1Nature, 2015
- Anchored multiplex PCR for targeted next-generation sequencingNature Medicine, 2014
- Fusions involving protein kinase C and membrane-associated proteins in benign fibrous histiocytomaThe International Journal of Biochemistry & Cell Biology, 2014